Aerovate's shares plummet as inhaled version of Novartis' Gleevac misses the mark in PAH trial
Aerovate's shares plummet as inhaled version of Novartis' Gleevac misses the mark in PAH trial
zbecker
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *